業績

2017年業績

欧文原著 - 当研究室の2017年の業績です。

  1. Masuzawa K, Yasuda H, Hamamoto J, Nukaga S, Hirano T, Kawada I, Naoki K, Soejima K, Betsuyaku T. Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations. Oncotarget. 2017 Nov 6;8(62):105479-105491. doi: 10.18632/oncotarget.22297. eCollection 2017 Dec 1. PMID: 29285266
  2. Kobayashi K, Naoki K, Kuroda A, Yasuda H, Kawada I, Soejima K, Betsuyaku T. A Case of EGFR-mutant Non-Small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with "Stop-And-Go" Osimertinib. Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9609-17. [Epub ahead of print] PMID: 29269665
  3. Okamori S, Asakura T, Masuzawa K, Yasuda H, Kamata H, Ishii M, Betsuyaku T. Suspected accelerated disease progression after discontinuation of nintedanib in patients with idiopathic pulmonary fibrosis: Two case reports. Medicine (Baltimore). 2017 Dec;96(49):e9081. doi: 10.1097/MD.0000000000009081. PMID: 29245325
  4. Kamata H, Asakura T, Suzuki S, Namkoong H, Yagi K, Funatsu Y, Okamori S, Uno S, Uwamino Y, Fujiwara H, Nishimura T, Ishii M, Betsuyaku T, Hasegawa N. Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease. BMC Pulm Med. 2017 Dec 13;17(1):198. doi: 10.1186/s12890-017-0544-x. PMID: 29237500
  5. Irie H, Chubachi S, Sato M, Tsutsumi A, Nakachi I, Miyao N, Nishio K, Nakamura H, Asano K, Betsuyaku T. Characteristics of patients with increasing COPD assessment test scores within 3 years. Respir Med. 2017 Oct;131:101-108. doi: 10.1016/j.rmed.2017.08.012. Epub 2017 Aug 14. PMID: 28947014
  6. Kurosawa H, Saisho Y, Fukunaga K, Haraguchi M, Yamasawa W, Kurihara I, Betsuyaku T, Itoh H. Association between severity of obstructive sleep apnea and glycated hemoglobin level in Japanese individuals with and without diabetes. Endocr J. 2017 Sep 20. doi: 10.1507/endocrj.EJ17-0356. [Epub ahead of print] PMID: 28931780
  7. Hamamoto J, Yasuda H, Aizawa K, Nishino M, Nukaga S, Hirano T, Kawada I, Naoki K, Betsuyaku T, Soejima K. Non-small cell lung cancer PC-9 cells exhibit increased sensitivity to gemcitabine and vinorelbine upon acquiring resistance to EGFR-tyrosine kinase inhibitors. Oncol Lett. 2017 Sep;14(3):3559-3565. doi: 10.3892/ol.2017.6591. Epub 2017 Jul 18. PMID: 28927112
  8. Namkoong H, Ishii M, Mori T, Sugiura H, Tasaka S, Sakurai M, Koda Y, Kato J, Hasegawa N, Okamoto S, Betsuyaku T. Clinical and radiological characteristics of patients with late-onset severe restrictive lung defect after hematopoietic stem cell transplantation. BMC Pulm Med. 2017 Sep 7;17(1):123. doi: 10.1186/s12890-017-0466-7. PMID: 28882120
  9. Nishino M, Ozaki M, Hegab AE, Hamamoto J, Kagawa S, Arai D, Yasuda H, Naoki K, Soejima K, Saya H, Betsuyaku T. Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinoma. J Cancer. 2017 Jul 1;8(10):1774-1785. doi: 10.7150/jca.19732. eCollection 2017. PMID: 28819374
  10. Matsusaka M, Fukunaga K, Kabata H, Izuhara K, Asano K, Betsuyaku T. Subphenotypes of type 2 severe asthma in adults. J Allergy Clin Immunol Pract. 2017 Aug 9. pii: S2213-2198(17)30499-3. doi: 10.1016/j.jaip.2017.06.015. [Epub ahead of print] No abstract available. PMID: 28803182
  11. Masaki K, Fukunaga K, Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, Kamatani T, Ohtsuka K, Baba R, Ueda S, Suzuki Y, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Kamei K, Izuhara K, Asano K, Betsuyaku T. Characteristics of severe asthma with fungal sensitization. Ann Allergy Asthma Immunol. 2017 Sep;119(3):253-257. doi: 10.1016/j.anai.2017.07.008. Epub 2017 Aug 8. PMID: 28801088
  12. Yagi K, Ishii M, Namkoong H, Asami T, Iketani O, Asakura T, Suzuki S, Sugiura H, Yamada Y, Nishimura T, Fujiwara H, Funatsu Y, Uwamino Y, Kamo T, Tasaka S, Betsuyaku T, Hasegawa N. The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases. BMC Infect Dis. 2017 Aug 9;17(1):558. doi: 10.1186/s12879-017-2665-5. PMID: 28793869
  13. Mashimo S, Chubachi S, Tsutsumi A, Kameyama N, Sasaki M, Jinzaki M, Nakamura H, Asano K, Reilly JJ Jr, Betsuyaku T. Relationship between diminution of small pulmonary vessels and emphysema in chronic obstructive pulmonary disease. Clin Imaging. 2017 Jul 18;46:85-90. doi: 10.1016/j.clinimag.2017.07.008. [Epub ahead of print] PMID: 28755581
  14. Asakura T, Hayakawa N, Hasegawa N, Namkoong H, Takeuchi K, Suzuki S, Ishii M, Betsuyaku T, Abe Y, Ouchi M.Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease.Clin Infect Dis. 2017 Mar 25. doi: 10.1093/cid/cix274. [Epub ahead of print]PMID: 28369361
  15. Masuzawa K, Asakura T, Ishii M, Yasuda H, Sugiura H, Betsuyaku T. Sternoclavicular joint osteomyelitis extending to lung abscess complicated by Staphylococcal infective endocarditis. IDCases. 2017 May 31;9:36-37. doi: 10.1016/j.idcr.2017.04.005. eCollection 2017.
  16. Chubachi S, Takahashi S, Tsutsumi A, Kameyama N, Sasaki M, Naoki K, Soejima K, Nakamura H, Asano K, Betsuyaku T. Radiologic features of precancerous areas of the lungs in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017 May 30;12:1613-1624. doi: 10.2147/COPD.S132709. eCollection 2017. PMID: 28615934
  17. Yotsukura M, Yasuda H, Shigenobu T, Kaseda K, Masai K, Hayashi Y, Hishida T, Ohtsuka T, Naoki K, Soejima K, Betsuyaku T, Asamura H. Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma. Lung Cancer. 2017 Jul;109:45-51. doi: 10.1016/j.lungcan.2017.04.014. Epub 2017 Apr 23.
  18. Shoji Y, Takeuchi H, Fukuda K, Fukunaga K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Miyasho T, Hiratsuka T, Inomata M, Betsuyaku T, Kitagawa Y. The alpha-lipoic acid derivative DHLHZn: a new therapeutic agent for acute lung injury in vivo. Inflamm Res. 2017 Jun 1. doi: 10.1007/s00011-017-1059-x. [Epub ahead of print]
  19. Namkoong H, Hasegawa N, Betsuyaku T. Susceptibility genes for nontuberculous mycobacterial disease.Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):60-67. doi: 10.2177/jsci.40.60.PMID: 28539556
  20. Masuzawa K, Minematsu N, Sasaki M, Ohsawa K, Yamamoto T, Iwamaru A, Ogata K, Betsuyaku T, Murakami M.Invasive mucinous adenocarcinoma of the lung presenting as a large, thin-walled cyst: A case report and literature review.Mol Clin Oncol. 2017 Mar;6(3):433-437. doi: 10.3892/mco.2017.1143. Epub 2017 Jan 31.PMID: 28451428
  21. Miyawaki M, Naoki K, Yoda S, Nakayama S, Satomi R, Sato T, Ikemura S, Ohgino K, Ishioka K, Arai D, Namkoong H, Otsuka K, Miyazaki M, Tani T, Kuroda A, Nishino M, Yasuda H, Kawada I, Koh H, Nakamura M, Terashima T, Sakamaki F, Sayama K, Betsuyaku T, Soejima K.Effects of the common polymorphism in the human aldehyde dehydrogenase 2 (ALDH2) gene on the lung.Mol Clin Oncol. 2017 Mar;6(3):409-414. doi: 10.3892/mco.2017.1154. Epub 2017 Feb 6.
  22. Kuroda A, Hegab AE, Jingtao G, Yamashita S, Hizawa N, Sakamoto T, Yamada H, Suzuki S, Ishii M, Namkoong H, Asakura T, Ozaki M, Yasuda H, Hamamoto J, Kagawa S, Soejima K, Betsuyaku T.Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).Mol Clin Oncol.Respir Res. 2017 Apr 21;18(1):69. doi: 10.1186/s12931-017-0554-5.PMID: 28431562
  23. Asakura T, Yamada Y, Namkoong H, Suzuki S, Niijima Y, Kamata H, Funatsu Y, Yagi K, Okamori S, Sugiura H, Ishii M, Jinzaki M, Betsuyaku T, Hasegawa N.Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium complex disease: A 3-dimensional computed tomographic analysis.Respir Med. 2017 May;126:9-16. doi: 10.1016/j.rmed.2017.03.010. Epub 2017 Mar 10.PMID: 28427555
  24. Asakura T, Arai D, Ishii M, Takei H, Sugiura H, Takeuchi T, Betsuyaku T.Pulmonary Cryptococcosis Developed from a Nodule after Treatment with Infliximab for Arthritis Associated with Ulcerative Colitis.Ann Am Thorac Soc. 2017 Apr;14(4):603-605. doi: 10.1513/AnnalsATS.201612-952LE. No abstract available.PMID: 28362530
  25. Mochimaru T, Minematsu N, Ohsawa K, Tomomatsu K, Miura H, Betsuyaku T, Murakami M.Hemoperitoneum Secondary to Rupture of a Hepatic Metastasis from Small Cell Lung Cancer during Chemotherapy: A Case with a Literature Review.Intern Med. 2017;56(6):695-699. doi: 10.2169/internalmedicine.56.6828. Epub 2017 Mar 17.PMID: 28321073
  26. Nomura H, Takahashi H, Suzuki S, Kurihara Y, Chubachi S, Kawada I, Yasuda H, Betsuyaku T, Amagai M, Funakoshi T.Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.J Dermatol. 2017 Mar 11. doi: 10.1111/1346-8138.13810. [Epub ahead of print]
  27. Mochimaru T, Kawada I, Chubachi S, Tsutsumi A, Hasegawa H, Betsuyaku T.Edoxaban treatment for pulmonary arterial thromboembolism associated with azygous vein aneurysm.Respirol Case Rep. 2017 Feb 26;5(3):e00223. doi: 10.1002/rcr2.223. eCollection 2017 May.PMID: 28250932
  28. Nukaga S, Yasuda H, Tsuchihara K, Hamamoto J, Masuzawa K, Kawada I, Naoki K, Matsumoto S, Mimaki S, Ikemura S, Goto K, Betsuyaku T, Soejima K. Amplification of EGFR wild type alleles in non-small cell lung cancer cells confers acquired resistance to mutation-selective EGFR tyrosine kinase inhibitors. Cancer Res. 2017 Feb 15. pii: canres.2359.2016. doi: 10.1158/0008-5472.CAN-16-2359. [Epub ahead of print] PMID: 28202511
  29. Intraoral ulcer due to non-invasive positive pressure ventilation: an overlooked complication. Masaki K, Chiyotani A, Nakachi I. BMJ Case Rep. 2017 Feb 21;2017. pii: bcr2017219201. doi: 10.1136/bcr-2017-219201. No abstract available. PMID: 28228388
  30. Maeda T, Fukunaga K, Nagata H, Haraguchi M, Kikuchi E, Miyajima A, Yamasawa W, Shirahama R, Narita M, Betsuyaku T, Asano K, Oya M. Obstructive sleep apnea syndrome should be considered as a cause of nocturia in younger patients without other voiding symptoms. Can Urol Assoc J. 2016 Jul-Aug;10(7-8):E241-E245. doi: 10.5489/cuaj.3508. PMID: 28255415
  31. Gao C, Fujinawa R, Yoshida T, Ueno M, Ota F, Kizuka Y, Hirayama T, Korekane H, Kitazume S, Maeno T, Ohtsubo K, Yoshida K, Yamaguchi Y, Lepenies B, Aretz J, Rademacher C, Kabata H, Hegab AE, Seeberger PH, Betsuyaku T, Kida K, Taniguchi N. A keratan sulfate disaccharide prevents inflammation and the progression of emphysema in murine models. Am J Physiol Lung Cell Mol Physiol. 2017 Feb 1;312(2):L268-L276. doi: 10.1152/ajplung.00151.2016. PMID: 28011617
  32. Soejima K, Yasuda H, Hirano T. Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer. Expert Rev Clin Pharmacol. 2017 Jan;10(1):31-38. doi: 10.1080/17512433.2017.1265446. PMID: 27885838.

業績一覧へ戻る

トピックス